Shan-Shan Wang, founder of Roam Technologies, has won the Sydney leg of the Startup World Cup with her innovative handheld oxygen device, Juno, earning a coveted place at the grand finale in Silicon Valley this November.
- Shan-Shan Wang’s Juno device wins Sydney Startup World Cup spot
- Competition judged by seasoned venture capitalists with strong mentorship
- Grand finale set for November in San Francisco with $1 million prize
What happened
The Sydney regional final of the Startup World Cup concluded with Shan-Shan Wang, CEO of Roam Technologies, winning the title for her handheld oxygen device designed for people with chronic respiratory conditions. This victory grants her a place at the global Startup World Cup grand finale in San Francisco on November 6, where the winner receives a $1 million investment.
The competition was run by Pegasus Tech Ventures, a Silicon Valley venture capital firm managing a $2 billion fund with over 100 regional events globally. Local events like Sydney's are highly competitive, with applicants receiving detailed investor feedback, pitch coaching, and personal branding sessions before final judging.
Why it matters
Wang’s success highlights Australia’s growing presence in the global medtech innovation landscape, particularly in devices that improve chronic condition management. Her product Juno is notable for its practical, everyday usability and has already attracted interest in the competitive US healthcare market.
The event’s rigorous, merit-based process and involvement of top-tier investors like David Kenney and Venture Capital panels underscore the quality of startups emerging from Australia. It also emphasizes ongoing support beyond competition outcomes, with all participants receiving valuable mentorship and exposure.
What to watch next
Attention now turns to the remaining Startup World Cup regional finals, including Queensland scheduled for early July, where another Australian startup will be selected to join the San Francisco grand finale alongside Wang and Melbourne winner Tori Fox. This final stage offers an opportunity for startups to secure significant funding and international visibility.
Observers should also watch how Wang’s Roam Technologies scales her product internationally post-competition. The traction gained in the US market could inform future rounds of investment, partnerships, and product development, further cementing Australia’s footprint in medtech innovation.